Medical Care Technologies Business Summary

Medical Care Technologies Inc. (MDCE) operates a diversified technology model that generates revenue through a mix of consumer-facing AI subscriptions, high-value collectible transactions, and AI-driven authentication services. The company’s primary business segments include its Consumer AI division, led by the recently launched "Snapshot Recipes" app which reached #12 in the iOS Food & Drink category in March 2026, and its Medical AI division, which focuses on patent-pending imaging technology for diagnostic pre-screening. Additionally, MDCE maintains revenue-generating subsidiaries, Infinite Auctions and Real Game Used, which provide non-dilutive capital through sports memorabilia sales and AI-based authentication. Positioned as a micro-cap innovator in the $208 billion AI-in-healthcare market, MDCE competes directly with established wellness platforms like MyFitnessPal and Noom, as well as specialized food analysis apps like Yuka. The company distinguishes itself through a lean, outsourced operational model and a unique bridge between consumer lifestyle tools and clinical-grade diagnostic applications. Leadership is centered under CEO and President Marshall Perkins III, who has spearheaded the company’s pivot into AI health-tech since 2022 and is a significant shareholder through consistent open-market acquisitions. Perkins’ strategic vision is informed by a personal recovery from advanced bone cancer, a narrative that drives the company’s focus on proactive health monitoring. The executive team includes Chief Technology Officer Sean Lee-Heung, who oversees the development of the company's proprietary deep learning engines, and Dr. Mark J. Langweiler, who serves as both Chief Operating Officer and Chief Medical Officer, bringing extensive clinical expertise to the medical pre-screening division. Other key officers include Hui Liu (Principal Financial Officer) and Tang Ping (Chief Marketing Officer). The board of directors was recently streamlined in February 2026 to align with the company’s aggressive global expansion into 127 countries, focusing on high-growth AI lifestyle and preventative medical technologies.